There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Icon plc (NASDAQ:ICLR) and Exact Sciences (NASDAQ:EXAS) with bullish sentiments.
Icon plc (ICLR)
Robert W. Baird analyst Eric Coldwell maintained a Buy rating on Icon plc today and set a price target of $157. The company’s shares closed yesterday at $145.50, close to its 52-week high of $150.18.
According to TipRanks.com, Coldwell is a 4-star analyst with an average return of 7.5% and a 53.2% success rate. Coldwell covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Walgreens Boots Alliance, and Quest Diagnostics Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Icon plc with a $152.86 average price target, which is a 5.1% upside from current levels. In a report released today, KeyBanc also maintained a Buy rating on the stock with a $157 price target.
.
See today’s analyst top recommended stocks >>
Exact Sciences (EXAS)
In a report released today, Catherine Schulte from Robert W. Baird maintained a Buy rating on Exact Sciences, with a price target of $85. The company’s shares closed yesterday at $75.99, close to its 52-week high of $80.35.
According to TipRanks.com, Schulte is a 5-star analyst with an average return of 31.6% and a 82.9% success rate. Schulte covers the Healthcare sector, focusing on stocks such as Bio-Techne Corporation, Oxford Immunotec, and NanoString Tech.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Exact Sciences with a $81.43 average price target, which is a 7.2% upside from current levels. In a report issued on September 5, Cowen & Co. also reiterated a Buy rating on the stock with a $100 price target.
.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on EXAS:
